Monistat 7 Combination Pack

Manufacturer
Insight Pharmaceuticals | Jubilant
Effective date
2013-03-01
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 01:41:27

Label at a glance#

ProductMonistat 7 Combination Pack Triple Action
Active ingredientMiconazole Nitrate
Label structure10 sections

Indications and uses

treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection

Dosage and administration

before using this product, read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: applicators: insert 1 applicatorful into the vagina at bedtime for 7 nights in a row. Throw away applicator after use. external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina (vu...

Storage and handling

do not use if seal over tube opening has been punctured do not purchase if carton is open store at 20°-25°C (68°-77°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredientsPurpose
Miconazole nitrate 2% (100 mg in each applicatorful)Vaginal antifungal
Miconazole nitrate 2% (external cream)Vaginal antifungal

Uses

INDICATIONS & USAGE SECTION

  • treats vaginal yeast infections
  • relieves external itching and irritation due to a vaginal yeast infection

Warnings

WARNINGS SECTION

For vaginal use only

OTC - DO NOT USE SECTION

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • vaginal itching and discomfort for the first time
  • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition.
  • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system.
  • been exposed to the human immunodeficiency virus (HIV) that causes AIDS

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur

OTC - WHEN USING SECTION

When using this product

  • do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs).
  • do not have vaginal intercourse
  • mild increase in vaginal burning, itching or irritation may occur
  • if you do not get complete relief ask a doctor before using another product

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • symptoms do not get better in 3 days
  • symptoms last more than 7 days
  • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • before using this product, read the enclosed consumer information leaflet for complete directions and information
  • adults and children 12 years of age and over:
  • applicators: insert 1 applicatorful into the vagina at bedtime for 7 nights in a row. Throw away applicator after use.
  • external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina (vulva). Use 2 times daily for up to 7 days, as needed.
  • children under 12 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • do not use if seal over tube opening has been punctured
  • do not purchase if carton is open
  • store at 20°-25°C (68°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

  • benzoic acid, cetyl alcohol, isopropyl myristate, polysorbate 60, potassium hydroxide, propylene glycol, purified water, stearyl alcohol

Questions?

OTC - QUESTIONS SECTION

call toll-free 877-666-4782

SPL UNCLASSIFIED SECTION

Distributed by: INSIGHT Pharmaceuticals, LLC., Trevose, PA 19053

PRINCIPAL DISPLAY PANEL - Kit Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

7 DAY TREATMENT • CREAM

MONISTAT® 7
Miconazole Nitrate Vaginal Cream (2%) and Miconazole Nitrate Cream (2%)
(Miconazole Nitrate 100 mg per application)
VAGINAL ANTIFUNGAL

CURES MOST VAGINAL YEAST INFECTIONS
and relieves associated external itching and irritation

CLINICALLY PROVEN
MULTI-SYMPTOM RELIEF

COMBINATION PACK
TRIPLE ACTION

#1 DOCTOR
RECOMMENDED BRAND†

Net Wt. 1.59 oz. (45g) • 0.32 oz. (9g) tube

Principal Display Panel - Kit Carton
Principal Display Panel - Kit Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63736-003-072020-06-29C16284748780-19d75b9d0-5bcc-f424-e053-dadaa90a57ceMonistat 7 Combination Pack Triple Action
63736-003-072020-01-31C16284748780-19d75b9d0-5bcc-f424-e053-dadaa90a57ceMonistat 7 Combination Pack Triple Action

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Miconazole NitrateACTIVE INGREDIENTVW4H1CYW1K2
MiconazoleACTIVE MOIETY7NNO0D7S5M2
BENZOIC ACIDINACTIVE INGREDIENT8SKN0B0MIM2
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN2
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS2
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4M2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1Y2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63736-00363736-003-07

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 180 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TAMPON / VAGINAL62.1 mgExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAMUSCULAR4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YOINTMENT / TOPICAL569 mgExact identifier — unii candidate
12 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YLOTION / TOPICAL1140 mgExact identifier — unii candidate
12 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET / ORAL64 mgExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / TOPICAL2.01 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSGEL / TOPICAL29 mgExact identifier — unii candidate
18 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MOINTMENT / TOPICAL2 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YTABLET, EXTENDED RELEASE / ORAL244 mgExact identifier — unii candidate
12 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, FILM COATED, EXTENDED RELEASE / ORAL59 mgExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / TOPICAL1800 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCREAM / VAGINAL200 mgExact identifier — unii candidate
20 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMINJECTION / INTRAVENOUS5 %w/vExact identifier — unii candidate
23 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
18 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YCAPSULE, EXTENDED RELEASE / ORAL72 mgExact identifier — unii candidate
12 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TSOLUTION / ORALADJ PHExact identifier — unii candidate
13 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMINJECTION, SOLUTION / INTRAMUSCULAR0.2 %w/vExact identifier — unii candidate
23 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSAEROSOL / TOPICAL9.3 %w/wExact identifier — unii candidate
18 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMSUPPOSITORY / VAGINAL2 mgExact identifier — unii candidate
23 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCAPSULE, DELAYED RELEASE / ORAL59 mgExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii candidate
81 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YTABLET, FILM COATED, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
12 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YPOWDER / ORAL0.11 mgExact identifier — unii candidate
12 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE, LIQUID FILLED / ORAL154 mgExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUPPOSITORY / VAGINAL252 mgExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSOIL / TOPICAL213 mgExact identifier — unii candidate
18 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSCREAM / VAGINAL50 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM, AUGMENTED / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPONGE / TOPICAL40 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MEMULSION / ORAL20 mg/1mlExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii candidate
81 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YTABLET / ORAL20 mgExact identifier — unii candidate
12 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMTABLET, FILM COATED / ORALNAExact identifier — unii candidate
23 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TRANSDERMAL500 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMLOTION / TOPICAL0.2 %w/wExact identifier — unii candidate
23 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE, EXTENDED RELEASE / ORAL0.07 mgExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYSTEM / TOPICAL4200 mgExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSGEL / TRANSDERMAL85 mgExact identifier — unii candidate
18 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNAEROSOL, FOAM / TOPICAL82 mgExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / VAGINAL1225 mgExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNAEROSOL, FOAM / RECTAL17 mgExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / RECTAL3315 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / RECTAL27 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMLIQUID / ORAL2 mg/1mlExact identifier — unii candidate
23 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNAEROSOL / TOPICAL1.16 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
BENZOIC ACIDBENZOIC ACID8SKN0B0MIMMOUTHWASH / BUCCALNAExact identifier — unii candidate
23 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAVENOUS16624 mgExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MSUSPENSION / TOPICAL2.85 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / DENTALNAExact identifier — unii candidate
81 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YSUPPOSITORY / VAGINAL8.5 mgExact identifier — unii candidate
12 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017450-002MONISTAT 7MICONAZOLE NITRATE2%CREAM / VAGINALRLD, RS1991-02-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-1584e616aacf4f…
2026-08-18 06:07:402026-07N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-1531067a03dcf5…
2025-08-23 18:47 UTC2025-08N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-156a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-1503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-152680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-155bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-1579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-151e350fbaab3a…
2024-05-31 18:47 UTC2024-05N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-158072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-155c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-155d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-154b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-1574a2ff9319b5…
2022-03-09 01:35 UTC2022-03N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-1587673890dc5c…
2021-03-12 10:30 UTC2021-03N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-155aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-158869cabd3fbd…
2020-11-12 02:37 UTC2020-11N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15c0c555d07b60…
2019-12-14 00:12 UTC2019-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-153f01610625f2…
2019-09-15 20:21 UTC2019-09N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15b00525d2431f…
2019-07-19 19:46 UTC2019-07N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-156a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-151c564ffb4f44…
2023-12-20 04:57 UTC2023-12N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-159b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-153f0d92c62455…
2023-05-13 08:27 UTC2023-05N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15053a50430f4f…
2023-01-26 05:58 UTC2023-01N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-153bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-153a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N017450-002MONISTAT 72%CREAM / VAGINALRLD, RS1991-02-15f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ab2cfe8d-2a1e-4f51-b578-b697d9b0ee4b18c41818-f0b5-4714-85d2-d1e9be7ce8fc2020-07-02WarningsExact identifier
spl set id: 18c41818-f0b5-4714-85d2-d1e9be7ce8fc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.